<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Procoagulant activity (<z:chebi fb="20" ids="36751">PCA</z:chebi>) of peripheral mononuclear cells (PMC) was evaluated in patients with <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">primary thrombocythemia</z:e> (PT, group A), <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>), idiopathic <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (IM) and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (group B), and in 15 healthy subjects as control group </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="20" ids="36751">PCA</z:chebi> of PMC was assayed under basal conditions and after <z:chebi fb="4" ids="48705">agonist</z:chebi>-induced stimulation: <z:mp ids='MP_0001794'>bacterial</z:mp> <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi>, glycosylated granulocyte-macrophage colony-stimulating factor, recombinant alpha-interferon </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="20" ids="36751">PCA</z:chebi> was similar in the control group and group A when no stimulation was used, while <z:chebi fb="20" ids="36751">PCA</z:chebi> was found significantly higher in group B patients in the same conditions </plain></SENT>
<SENT sid="3" pm="."><plain>In group A patients and in the control group, but not in group B patients, a lower <z:chebi fb="20" ids="36751">PCA</z:chebi> expression was found when PMC were simultaneously coincubated with LPS and alpha-interferon with respect to LPS incubation alone </plain></SENT>
</text></document>